{Reference Type}: Journal Article
{Title}: Genetic Heterogeneity in Cellular Angiofibromas.
{Author}: Panagopoulos I;Andersen K;Lobmaier I;Lund-Iversen M;
{Journal}: Genes Chromosomes Cancer
{Volume}: 63
{Issue}: 8
{Year}: 2024 Aug
{Factor}: 4.263
{DOI}: 10.1002/gcc.23262
{Abstract}: <B>BACKGROUND: </B>Cellular angiofibroma, a rare benign mesenchymal neoplasm, is classified within the 13q/RB1 family of tumors due to morphological, immunohistochemical, and genetic similarities with spindle cell lipoma. Here, genetic data reveal pathogenetic heterogeneity in cellular angiofibroma.<BR><B>METHODS: </B>Three cellular angiofibromas were studied using G-banding/Karyotyping, array comparative genomic hybridization, RNA sequencing, and direct cycling sequencing.<BR><B>RESULTS: </B>The first tumor carried a del(13)(q12) together with heterozygous loss and minimal expression of the RB1 gene. Tumors two and three displayed chromosome 8 abnormalities associated with chimeras of the pleomorphic adenoma gene 1 (PLAG1). In tumor 2, the cathepsin B (CTSB) fused to PLAG1 (CTSB::PLAG1) while in tumor 3, the mir-99a-let-7c cluster host gene (MIR99AHG) fused to PLAG1 (MIR99AHG::PLAG1), both leading to elevated expression of PLAG1 and insulin growth factor 2.<BR><B>CONCLUSIONS: </B>This study uncovers two genetic pathways contributing to the pathogenetic heterogeneity within cellular angiofibromas. The first aligns with the 13q/RB1 family of tumors and the second involves PLAG1-chimeras. These findings highlight the diverse genetic landscape of cellular angiofibromas, providing insights into potential diagnostic strategies.